Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Vaccination errors
Filetype[PDF-1.67 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Frequency and Cost of Vaccinations Administered Outside Recommended Ages — 2014; Six Immunization Information System Sentinel Sites
    Personal Author:
    Rodgers, Loren; Shaw, Lauren; Strikas, Raymond; Hibbs, Beth; Wolicki, JoEllen; Cardemil, Cristina; Weinbaum, Cindy;
    Published Date:
    December 14 2017
    Source:
    J Pediatr. 193:164-171
    Description:
    Objective:To quantify vaccinations outside recommended ages by analyzing immunization information system (IIS) records.Study Design:We analyzed de-identified records of doses administered during 2014 to persons age ≤17 years within six IIS Sentinel...
    File Type:
    Filetype[PDF - 108.69 KB]
  2. National 2009 H1N1 Flu Survey (NHFS) : a user's guide for the public-use data file
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases(U.S.). National Center for Health Statistics (U.S.). NORC (Organization).
    Published Date:
    March 2012
    File Type:
    Filetype[PDF - 1.04 MB]
  3. Rotavirus Vaccine Administration Errors — United States, 2006–2013
    Personal Author:
    Hibbs, Beth F.; Miller, Elaine R.; Shimabukuro, Tom T.;
    Published Date:
    Jan 31 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(4):81.
    Description:
    Two live rotavirus oral vaccines, RotaTeq (RV5) (Merck & Co., Inc.) and Rotarix (RV1) (GlaxoSmithKline Biologicals), are approved for prevention of rotavirus gastroenteritis and recommended at ages 2, 4 (RV5/RV1), and 6 (RV5) months by the Advisory C...
    File Type:
    Filetype[PDF - 118.30 KB]
  4. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
    Personal Author:
    Hesse, Elisabeth M.; Shimabukuro, Tom T.; Su, John R.; Hibbs, Beth F.; Dooling, Kathleen L.; Goud, Ravi; Lewis, Paige; Ng, Carmen S.; Cano, Maria V.;
    Published Date:
    February 01 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(4):91-94
    Description:
    Recombinant zoster vaccine (RZV; Shingrix), an adjuvanted glycoprotein vaccine, was licensed by the Food and Drug Administration (FDA) and recommended by the Advisory Committee on Immunization Practices for adults aged ≥50 years in October 2017 (1)...
    File Type:
    Filetype[PDF - 180.36 KB]
  5. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007–2017
    Personal Author:
    Moro, Pedro L.; Arana, Jorge; Marquez, Paige L.; Ng, Carmen; Barash, Faith; Hibbs, Beth F.; Cano, Maria;
    Published Date:
    May 30 2019
    Source:
    Vaccine. 37(28):3730-3734
    Description:
    Background:The administration of an extra dose of a vaccine may occur due to a programmatic error (e.g., vaccination error) when there is need to provide one of the antigens of a combination vaccine not readily available as a single antigen, or when ...
    File Type:
    Filetype[PDF - 76.95 KB]